Long-term endothelin a receptor blockade inhibits electrical remodeling in cardiomyopathic hamsters

Area of Science:

• Cardiovascular Research
• Pharmacology
• Electrophysiology

Background:

• The endothelin (ET) system is implicated in heart failure.
• Congestive heart failure is linked to ventricular arrhythmias due to electrical remodeling.
• Electrical remodeling involves changes in ionic current density and action potential duration.

Purpose of the Study:

• To investigate the effects of long-term ET(A) receptor blockade on electrophysiological properties.
• To assess the impact on surface ECG and survival in BIO 14.6 cardiomyopathic hamsters.

Main Methods:

• Recorded membrane currents and action potentials from ventricular cells of normal and cardiomyopathic hamsters.
• Compared untreated cardiomyopathic hamsters with those chronically treated with an ET(A) receptor antagonist (TA-0201).

Main Results:

• Untreated cardiomyopathic hamsters showed prolonged action potential duration and reduced ionic currents (I(Ca,L), I(to), I(K), I(K1)).
• ET(A) receptor antagonist treatment attenuated action potential prolongation and preserved ionic current densities.
• Long-term blockade prevented QT prolongation, ventricular arrhythmias, and improved survival rates.

Conclusions:

• Long-term ET(A) antagonist treatment inhibits electrical remodeling in cardiomyopathic hearts.
• This blockade suppresses ventricular arrhythmias by normalizing K+ and Ca2+ currents and action potential duration.
• ET(A) receptor blockade presents a potential therapeutic strategy for arrhythmias in heart failure.